PrimeRFP SCOUT · Federal Contract Recompete Brief

36C24724F0143Haegarda injections — Csl Behring L.L.C

The prior award was single-bid — competitive dynamics may favor a challenge. PoP ended Nov 27, 2024 — the usual 12–18 month planning window is closed; recompete action looks late or overdue.

247-Network Contract Office 7 (36C247)

Awarding office

Csl Behring L.L.C

Recipient

Nov 27, 2024

PoP end

$117K

Obligated

$136K

Potential

325412

NAICS

Q517

PSC

1 bidders on last award

Watch this recompete

One email. No account. We ping you if the window moves.

Score my position vs Csl Behring L.L.C — $90

Contract facts

Federal

Contract number36C24724F0143

Also listed as36C247-24-F-0143

Also listed as36F79721D0249-36C24724F0143

Agency247-Network Contract Office 7 (36C247)

Awarding office247-Network Contract Office 7 (36C247)

Awarding agencyDepartment of Veterans Affairs (VA)

Funding agencyDepartment of Veterans Affairs (VA)

IncumbentCsl Behring L.L.C

CAGE07PZ8

UEIH3WKVE9VBLY3

NAICS325412

No full NAICS 325412 intel page yet. Browse NAICS intelligence

PSCQ517

Parent IDIQ / IDV36F79721D0249

Place of performanceDUBLIN GA

Pricing typeFirm Fixed Price

Extent competedFull And Open Competition

PoP startJan 1, 2024

PoP end (current)Nov 27, 2024

Obligated$117K

Current value$136K

Potential value$136K

HAEGARDA INJECTIONS is a federal award for 247-Network Contract Office 7 (36C247) held by Csl Behring L.L.C. Estimated value $136K ($117K obligated). Current period of performance ends Nov 27, 2024. Last award drew 1 bidder. Place of performance: DUBLIN GA.

Recompete timing

Public

● Past PoP end (632 days ago)

Current PoP ended Nov 27, 2024 (632 days ago). The usual 12–18 month agency planning window is closed — recompete action looks late / overdue relative to a normal cycle. Watch for bridge orders, follow-ons, or a new solicitation.

Query this award live in SCOUT via MCP — personalized scoring, watchlists, and capture workflow across the corpus. Learn about SCOUT MCP →

Frequently asked questions

What is contract 36C24724F0143?

36C24724F0143 (Haegarda injections) is a 247-Network Contract Office 7 (36C247) award with a potential value of $136K, currently held by Csl Behring L.L.C. Figures are USASpending-sourced public-record facts plus SCOUT recompete analysis.

What is 36C247-24-F-0143?

36C247-24-F-0143 is the dashed form of PIID 36C24724F0143 (Haegarda injections), held by Csl Behring L.L.C. Same award — SCOUT canonicalizes compact, dashed, and parent-child identifiers to one brief.

Which office awarded 36C24724F0143?

247-Network Contract Office 7 (36C247) awarded 36C24724F0143 to Csl Behring L.L.C (potential $136K).

Who is the incumbent on 36C24724F0143?

Csl Behring L.L.C is the incumbent. The current period of performance ends Nov 27, 2024.

When does Csl Behring L.L.C’s 36C24724F0143 come up for recompete?

SCOUT tracks a period-of-performance end of Nov 27, 2024. Actual solicitation timing can shift with extensions, bridges, or consolidations.

Data: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows.

Data as of Nov 27, 2024 · refreshed monthly